AzTrials
AzTrials

Adipose Tissue Gene ExpressionNCT02870075

The Influence of Different Dietary Status on the Acute Responses to Exercise

A study testing Fed exercise and Fasted exercise in people with Adipose Tissue Gene Expression, run by University of Bath.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate whether dietary conditions (fed versus fasted) affects the acute responses to exercise. Read more about this study

Who is it for?
Ages 18 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Adipose Tissue Gene Expression
What is being tested?
Fed exercise and Fasted exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
May 2013to Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Aged between 18 to 35 years
  • Central overweight (waist circumference 94-128 cm)
  • Weight stable for more than 3 months (no change in weight +/- 3%)
  • Non-smoker
  • Able to walk for a long period of time

Who cannot join

  • Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia
  • Waist circumference < 94cm and >128cm
  • Taking medications that may influence lipid or carbohydrate metabolism or immune system function
  • Unable to take part in structured exercise for any reason (e.g., injury or disability) or a positive response to any questions on the Physical Activity Readiness questionnaire (PAR-Q)

About this study

The purpose of this study is to investigate whether dietary conditions (fed versus fasted) affects the acute responses to exercise.

Read the detailed description

Pre-trial assessments

V̇O2max measurement V̇O2max was determined using an incremental continuous treadmill test until the point of volitional exhaustion. For most participants, a treadmill speed of 4 km/h and gradient of 8.5% was chosen. Participants were tested at this speed and gradient with the speed increased by 1 km/h after every 3 min stage. One minute expired air samples were collected into Douglas bags (Douglas Bags, Hans Rudolph, MO, USA), and RPE and heart rates were measured in the final minute of each stage and also at the point of volitional exhaustion, defined as when the participant indicated that only 1 min remained until fatigue. Samples were analysed for relative expired fractions of oxygen and carbon dioxide gas (Servomex, Crowborough, UK) and the total volume with in the bag was measured using a dry gas meter (Harvard Apparatus, Kent, UK).

Physical activity assessment Participants wore a combined heart rate/accelerometer monitor for one week to assess their habitual physical activity energy expenditure (Actiheart, Cambridge Neurotechnology Ltd., Cambridge, UK). This was attached to the left chest via 2 adhesive ECG pads for 24 hours per day except for during showering/bathing/swimming.

Body composition analysis Body mass was measured using digital scales post-void (TANITA corp., Tokyo, Japan). Waist and hip circumference was assessed according to World Health Organisation guidelines. Body composition was determined using Dual energy X-ray absorptiometry (Discovery, Hologic, Bedford, UK). Abdominal subcutaneous and visceral adipose tissue mas was estimated from a central region between L1-L4.

Trial days In the 72 h prior to each main trial, participants were asked to refrain from performing any strenuous physical activity and from consuming alcohol/caffeine for 48 h prior to the main trials. A dietary record was completed 48 h before the first main trial and participants were asked to replicate this diet prior to their second main trial.

On main trial days, participants arrived at the laboratory between 8-9am following a 12 h fast. After anthropometric measurements, participants rested on a bed for 15 minutes, followed by four 5 min expired gas samples collections to determine resting metabolic rate (RMR) using substrate oxidation under resting conditions.

Participants then either consumed a meal (FED) or remained fasting (FASTED) and cannula blood samples were taken every 15 minutes for the following 60 minutes. A further blood sample was collected at 120 min immediately before the walking protocol. In both the FASTED and FED treatments, participants walked on the treadmill at 60% V̇O2max for 60 minutes and one minute of expired air samples, ratings of perceived exertion (RPE) and heart rate were collected at 5, 20, 40 and 60 minutes. After finishing the exercise, another blood sample was immediately collected and participants then rested for a further 60 minutes. At this point, a second adipose tissue and final blood sample was taken.

Adipose tissue culture and gene expression After adipose tissue biopsy and cleaning, tissue was minced to approximately 5-10 mg and directly placed in sterile culture plates (Nunc, Roskilde, Denmark) with endothelial cell basal media (ECBM) containing 0.1% fatty acid-free bovine serum albumin 100 U ml-1 penicillin and 0.1 mg ml-1 streptomycin (Sigma-Aldrich, Gillingham, UK). Adipose tissue was incubated with a final ratio of 100mg tissue per 1 ml ECBM media for 3 hours. A 37°C, 5% CO2 and 95 ± 5% relative humidity incubator was used (MCO-18A1C CO2 incubator; Sanyo, Osaka, Japan). Media was transferred to sterile eppendorfs and stored at -80°C after 3 hours incubation. Approximately 200 mg adipose tissue was homogenised in 5ml Trizol in an RNase/DNase-free sterile tube (Invitrogen, Paisley, UK) and stored at -80°C before further analysis.

Sample size There is no data regarding how different dietary status (fed versus fasted) affects the acute responses to exercise on overweight males. However, a previous study using a similar meal showed that feeding had an enormous effect on the use of lipid during exercise - and thus indicates that the role of adipose tissue during exercise would be potentially very different. In order to see an effect on lipid oxidation during exercise with 95% power and 5% alpha, we would require 6-8 participants. To ensure that these results are generalizable and also to account for greater variability in other outcome, we recruited a total 10 participants from the study.

Statistics:

All data was presented as mean ± standard error of mean (SEM). Incremental area under curve (iAUC) was calculated using the trapezoid method and differences between trials analysed using paired t-tests. Glucose, insulin, NEFA, TAG, adipokines, and cell culture outcomes were determined using a two-way ANOVA with repeated measures using SPSS version 22 (IBM, Armonk, NY, USA). Where significant interactions (trial × time) were found, a post hoc analysis was applied using t-test with the Holm-Bonferroni correction. Single comparisons used a t-test or non-parametric equivalent. Statistical significance was set at p ≤ 0.05.

Being tested
Fed exercise, Fasted exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fed exerciseBehavioural

    Participants consumed a meal (Fed) 2 h prior to 1 h moderate intensity exercise at 60% VO2max.

  • Fasted exerciseBehavioural

    Participants remained fasting (Fasted) 2 h prior to 1 h moderate intensity exercise at 60% VO2max.

Study groups in NCT02870075
Study groupRoleWhat they receive
Fed exerciseActive comparatorFed prior to exercise
Receives: Behavioral: Fed exercise
Fasted exerciseActive comparatorFasted prior to exercise
Receives: Behavioral: Fasted exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in gene expression in the adipose tissue

    Measured: Before the meal and 1 h after exercise (255 minutes)

Secondary outcomes (3)
  1. Changes in insulin, glucose, TAG and NEFA in blood

    Measured: 255 minutes

  2. Changes in serum Interleukin-6 (IL-6), leptin and adiponectin

    Measured: 255 minutes

  3. Changes in Interleukin-6 (IL-6), leptin and adiponectin protein secretion from adipose tissue explants

    Measured: Before the meal and 1 h after exercise (255 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2016 (estimated)
  2. Study startMay 2013
  3. Primary completionOct 2014
  4. Study completionJan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02870075
Sponsor's protocol ID
13/SW/0020
Status last verified
Aug 2016
First submitted
9 Feb 2016
Last updated
17 Aug 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Chen YC, Travers RL, Walhin JP, Gonzalez JT, Koumanov F, Betts JA, Thompson D. Feeding influences adipose tissue responses to exercise in overweight men. Am J Physiol Endocrinol Metab. 2017 Jul 1;313(1):E84-E93. doi: 10.1152/ajpendo.00006.2017. Epub 2017 Mar 14.

    PubMed 28292758

Questions about this trial

What is this clinical trial studying?

A study testing Fed exercise and Fasted exercise in people with Adipose Tissue Gene Expression, run by University of Bath.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in gene expression in the adipose tissue (time frame: Before the meal and 1 h after exercise (255 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02870075, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in